N
NEUP
Neuphoria Therapeutics Inc
5.48
+0.36+7.03%After Hours: 5.42 -0.06 -1.09%18:10 05/22 EDT
OPEN/PREV CLOSE5.20/5.12
TODAY RANGE5.16-5.53
VOL141.92K
MARKET CAP29.62M
52 WEEK RANGE3.645-21.40
AVG VOL (3M)52.63K
% TURNOVER2.63%
TURNOVER--
P/E (TTM)-2.5843
% RANGE7.03%
EPS(TTM)-2.1205
P/E(FORWARD)-1.3464
P/B0.9922
BVPS5.52
DIVIDEND--
P/S0.6928
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP27.34M
SHARES OUTSTANDING5.40M
NEXT EARNINGS--
FREE FLOAT4.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·05/15 18:44
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy
TipRanks·05/15 18:23
Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Dow Jones·05/15 17:43
Neuphoria Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Benzinga·05/15 17:34
HC Wainwright & Co. Downgrades Neuphoria Therapeutics to Neutral
Benzinga·05/15 13:23
Neuphoria Therapeutics Q3 EPS $(0.09) Beats $(0.97) Estimate
TipRanks·01/08 11:32
Neuphoria Therapeutics Announces CEO Transition and Consulting Role
TipRanks·12/17/2025 21:39
Neuphoria Therapeutics Shareholders Align on Key Proposals
TipRanks·12/08/2025 13:05
Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees
Dow Jones·12/05/2025 13:05
Neuphoria Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·12/05/2025 13:05
Neuphoria Therapeutics Price Target Cut to $7.00/Share From $21.00 by HC Wainwright & Co.
Benzinga·12/05/2025 12:55
HC Wainwright & Co. Maintains Buy on Neuphoria Therapeutics, Lowers Price Target to $7
TipRanks·12/05/2025 12:50
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA)